1. Recent Developments and Emerging Therapies for Type 2 Diabetes Mellitus

   • Alison J. Evans
   • Andrew J. Krentz

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 75 - 94

2. Agents in Development for Type 2 Diabetes

   • Blair Jarvis
   • Shelley Elkinson

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 95 - 99

3. BTS 67582

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 101 - 102

4. Insulin Aspart

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 103 - 106

5. Insulin Glargine

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 107 - 109

6. Insulin Inhalation (Aradigm Corporation)

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 110 - 111

7. Insulin Inhalation (Pfizer/Inhale Therapeutic Systems)

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 112 - 113

8. Mitiglinide

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 114 - 115

9. PMS 812

   Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 116 - 117

10. Pramlintide

    Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 118 - 122

11. Senaglinide

    Section 1: Type 2 Diabete Mellitus 11 December 2012 Pages: 123 - 126

12. Agents in Development for Dementia Syndromes in Japan

    • Kate Palmer
    • Joanne Dalton

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 129 - 132

13. Azetirelin

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 133 - 134

14. Fasoracetam

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 135 - 136

15. Nefiracetam

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 137 - 141

16. Perospirone

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 142 - 143

17. Sufoxazine

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 144 - 145

18. TJ 960

    Section 2: Dementia Syndrome in Japan 11 December 2012 Pages: 146 - 146